Clinical Trial Update: Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS) [Phase 4]

View source ↗

Summary

This document reports on a Phase 4 clinical trial evaluating roflumilast to prevent exacerbations in patients with fibrotic sarcoidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: University of Cincinnati | Conditions: Sarcoidosis | Phase 4 | Status: UNKNOWN